Cloning and molecular characterization of human high affinity antibody fragments against Hepatitis C virus NS3 helicase

Journal of Virological Methods

Volumn 103, Issue 1, 2002, Pages 75-88

  Tessmann, Kathi ^a   Erhardt, Andreas ^a   Häussinger, Dieter ^a   Heintges, Tobias ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Helicase; Human antibody sFv fragment; Intracellular immunization; NS3; Phage display

Indexed keywords

COMPLEMENTARY DNA; HELICASE; HEPATITIS C ANTIBODY; RECOMBINANT ANTIBODY; VIRUS ENZYME;

AMINO ACID SEQUENCE; ANTIBODY AFFINITY; ANTIBODY ISOLATION; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; BACTERIOPHAGE; BACTERIUM; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISSOCIATION CONSTANT; ENZYME INHIBITION; EXPRESSION VECTOR; GENE THERAPY; GENETIC TRANSDUCTION; GERM LINE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNIZATION; MOLECULAR CLONING; PHAGEMID; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANTIGEN-ANTIBODY REACTIONS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; GENES, IMMUNOGLOBULIN; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOSORBENT TECHNIQUES; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; RECOMBINANT FUSION PROTEINS; RNA HELICASES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0036130493     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-0934(02)00017-4     Document Type: Article

References (49)

1. Kinetic and structural analyses of hepatitis C virus polyprotein processing
2. Functional human monoclonal antibodies of all isotypes constructed from phage display library-derived single-chain Fv antibody fragments
3. Inhibition of HIV-1 by an anti-integrase single-chain variable fragment (SFv): Delivery by SV40 provides durable protection against HIV-1 and does not require selection
4. Intracellular antibodies as a new class of therapeutic molecules for gene therapy
5. Combined intra- and extracellular immunization against human immunodeficiency virus type 1 infection with a human anti-gp120 antibody
6. Crystal structure of RNA helicase from genotype 1b hepatitis C virus. A feasible mechanism of unwinding duplex RNA
7. Targeted tumor killing via an intracellular antibody against erbB-2
8. Liver-directed gene transfer vectors
9. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay
10. Methods for measurement of antibody/antigen affinity based on ELISA and RIA
11. Expression and identification of hepatitis C virus polyprotein cleavage products
12. In vitro selection and affinity maturation of antibodies from a naive combinatorial immunoglobulin library
13. DNA helicase activity of the hepatitis C virus nonstructural protein 3
14. Proteolytic processing and membrane association of putative nonstructural proteins of hepatitis C virus
15. By-passing immunization. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro
16. An ELISA for RNA helicase activity: Application as an assay of the NS3 helicase of hepatitis C virus
17. Inhibition of tumor growth and metastasis of human melanoma by intracellular anti-ATF-1 single chain Fv fragment
18. Mutational analysis of the hepatitis C virus RNA helicase
19. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding
20. Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase
21. An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments
22. Specificity of the hepatitis C virus NS3 serine protease: Effects of substitutions at the 3/4A, 4A/4B, 4B/5A, and 5A/5B cleavage sites on polyprotein processing
23. Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system
24. Detection of hepatitis C virus helicase activity using the scintillation proximity assay system
25. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
26. Intrabodies: Turning the humoral immune system outside in for intracellular immunization
27. Human anti-HIV-1 tat sFv intrabodies for gene therapy of advanced HIV-1-infection and AIDS
28. By-passing immunization. Human antibodies from V-gene libraries displayed on phage
29. Accessing the Kabat antibody sequence database by computer
30. Phage antibodies: Filamentous phage displaying antibody variable domains
31. Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies
32. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
33. Construction and use of antibody gene repertoires
34. Inhibition of human immunodeficiency virus replication and growth advantage of CD4+ T cells from HIV-infected individuals that express intracellular antibodies against HIV-1 gp120 or Tat
35. A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain
36. Phage display of combinatorial antibody libraries
37. Intrabody-mediated knockout of the high-affinity IL-2 receptor in primary human T cells using a bicistronic lentivirus vector
38. Internal processing of hepatitis C virus NS3 protein
39. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli
40. Activity of purified hepatitis C virus protease NS3 on peptide substrates
41. Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related pestivirus and flavivirus enzymes
42. NS3 is a serine protease required for processing of hepatitis C virus polyprotein
43. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein
44. Making antibodies by phage display technology
45. Internal cleavage of hepatitis C virus NS3 protein is dependent on the activity of NS34A protease
46. Structure of the hepatitis C virus RNA helicase domain
47. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo